+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Foot and Mouth Disease (FMD) Vaccine - Global Strategic Business Report

  • PDF Icon

    Report

  • 93 Pages
  • November 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5302756
The global market for Foot and Mouth Disease (FMD) Vaccine was estimated at US$3.1 Billion in 2023 and is projected to reach US$5.6 Billion by 2030, growing at a CAGR of 9.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Foot and Mouth Disease (FMD) Vaccine Market - Key Trends & Drivers Summarized

What Are the Current Challenges Driving Demand for FMD Vaccines?

The global demand for Foot and Mouth Disease (FMD) vaccines has been steadily rising as the virus continues to pose a severe threat to livestock industries around the world. How is the increasing prevalence of the disease impacting livestock markets, and why is vaccination crucial? FMD is a highly contagious viral disease that affects cloven-hoofed animals, including cattle, pigs, sheep, and goats. The rapid transmission of the virus across borders has made it a persistent issue, particularly in regions where livestock plays a pivotal role in local economies. The outbreaks not only affect animal health but also disrupt food supply chains, lead to substantial economic losses, and trigger widespread culling of livestock. The resulting financial burden from reduced productivity and trade restrictions has incentivized governments to implement mass vaccination programs to control and prevent further spread. In regions where FMD is endemic, especially in Asia, Africa, and South America, preventive measures, including routine vaccinations, have become essential in reducing the incidence of outbreaks and safeguarding food security. Consequently, these regions are seeing a growing demand for more effective, long-lasting vaccines to mitigate the damage caused by FMD.

How Are Technological Innovations Shaping the Future of FMD Vaccination?

Technological advancements have revolutionized the development and distribution of FMD vaccines, offering new solutions to an age-old problem. How are innovations in vaccine technology changing the way the disease is managed? While traditional inactivated vaccines have long been the standard, recent innovations in the field of biotechnology have led to the emergence of DNA and recombinant vaccines, which offer improved efficacy and longer immunity periods. DNA vaccines work by introducing specific genetic material that triggers an immune response, potentially offering quicker and more durable protection against FMD. Meanwhile, recombinant vaccines, which are produced using genetic engineering, help minimize the risks associated with incomplete virus inactivation, making them safer and more effective for widespread use. Another significant advancement is the introduction of novel adjuvants, which enhance the immune response and extend the vaccine`s effectiveness, thus reducing the frequency of re-vaccination. Additionally, there have been breakthroughs in vaccine delivery systems, such as needle-free injectors and transdermal patches, which simplify the administration process, making it easier to vaccinate large herds in remote areas. These advancements are not only increasing the overall efficiency of vaccination campaigns but are also crucial in ensuring that vaccines reach all regions affected by FMD, especially where resources and infrastructure are limited.

How Are Regulatory and Economic Pressures Impacting the FMD Vaccine Market?

The regulatory and economic landscape surrounding FMD control is complex and has a direct influence on vaccine adoption and distribution. What role do regulations and economic factors play in shaping this market? Governments and international organizations such as the World Organisation for Animal Health (OIE) and the Food and Agriculture Organization (FAO) play a central role in guiding global efforts to control FMD. In many countries where FMD poses a significant risk, vaccination programs are government-mandated, with strict regulations ensuring that vaccines meet the required safety and efficacy standards. The economic implications of FMD outbreaks are vast, often resulting in trade restrictions, lost productivity, and significant financial losses due to the need for mass culling of infected livestock. In response to these challenges, many countries have adopted preventive vaccination programs as a critical component of their animal health strategies. Furthermore, in regions heavily reliant on livestock exports, such as South America and parts of Asia, adherence to international standards is crucial for maintaining access to lucrative markets. The high costs associated with FMD outbreaks and the importance of maintaining uninterrupted trade have spurred a growing commitment to routine vaccinations, driving the demand for more advanced vaccines that meet regulatory standards and provide longer-lasting immunity.

What Factors Are Driving the Growth of the FMD Vaccine Market?

The growth in the FMD vaccine market is driven by several factors, including technological advancements, expanding livestock industries, and changing consumer behaviors. Technological progress in vaccine development, such as the creation of DNA and recombinant vaccines, has led to improved efficacy and safety, increasing the attractiveness of newer vaccine options. The expansion of the commercial livestock sector, particularly in emerging markets like Asia-Pacific, Latin America, and Africa, is fueling demand for vaccines as farmers and governments seek to protect livestock from disease and enhance productivity. Changing consumer preferences for ethically sourced and disease-free animal products are also playing a significant role in shaping demand. The increasing global emphasis on food safety and sustainable farming practices is pushing farmers to adopt vaccination strategies that prioritize animal welfare and public health. Moreover, improvements in cold-chain logistics and supply networks are making it easier to distribute vaccines to remote and underserved areas, allowing for wider access and greater market penetration. Lastly, the rising incidence of FMD outbreaks worldwide has led to stronger governmental and international support for vaccination programs, with large-scale investments being made to ensure that livestock populations are adequately protected against this costly and devastating disease. These factors collectively form the foundation for the sustained growth and expansion of the FMD vaccine market in the coming years.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Conventional Vaccines segment, which is expected to reach US$3.3 Billion by 2030 with a CAGR of a 7.8%. The Emergency Vaccines segment is also set to grow at 10.9% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $803.9 Million in 2023, and China, forecasted to grow at an impressive 13.0% CAGR to reach $1.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Foot and Mouth Disease (FMD) Vaccine Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Foot and Mouth Disease (FMD) Vaccine Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Foot and Mouth Disease (FMD) Vaccine Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Foot and Mouth Disease (FMD) Vaccine Market such as Agrovet Co, Beohringer Ingelheim, Biogénesis Bagó, Brilliant Bio Pharma Ltd., Ceva Santé Animale and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 42 companies featured in this Global Foot and Mouth Disease (FMD) Vaccine market report include:

  • Agrovet Co
  • Beohringer Ingelheim
  • Biogénesis Bagó
  • Brilliant Bio Pharma Ltd.
  • Ceva Santé Animale
  • Empresa Colombiana de Productos Veterinarios S.A. VECOL S.A.
  • FMD Center
  • Godrej Agrovet Limited
  • Indian Immunologicals Limited
  • Limor de Colombia
  • Merck Animal Health
  • Merial S. A. S.
  • Vecol SA
  • Vetal Animal Health Products
  • Veterinary Serum and Vaccine Research Institute

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Global Economic Update
  • Foot and Mouth Disease (FMD) Vaccine - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Foot and Mouth Disease (FMD) in Livestock Drives Demand for Preventative Vaccines
  • Government and International Health Initiatives to Control FMD Outbreaks Propel Vaccine Adoption Worldwide
  • Technological Advancements in Vaccine Development and Manufacturing Improve Efficacy and Availability of FMD Vaccines
  • Increasing Focus on Livestock Health and Productivity Expands the Market for FMD Vaccination Programs
  • Growing Meat and Dairy Consumption Fuels Demand for FMD Vaccines to Protect Livestock Health and Ensure Food Safety
  • Expansion of Animal Husbandry and Agricultural Activities in Emerging Economies Spurs Adoption of FMD Vaccines
  • Rising Economic Impact of FMD Outbreaks on the Livestock Industry Drives Adoption of Comprehensive Vaccination Strategies
  • Innovations in Multivalent and Thermostable Vaccines Enhance Market Opportunities for Effective FMD Control
  • Globalization of Livestock Trade and Increased Risk of Cross-Border Disease Transmission Spur Demand for FMD Vaccines
  • Growing Focus on Sustainable Agriculture and Animal Welfare Drives Vaccine Adoption to Prevent Disease Outbreaks
  • Advances in Biotechnology and Genetic Engineering Propel Development of Next-Generation FMD Vaccines with Higher Potency
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Conventional Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Conventional Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Conventional Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Emergency Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Emergency Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Emergency Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Cattle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Cattle by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Cattle by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Sheep & Goat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Sheep & Goat by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Sheep & Goat by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Pigs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Pigs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Pigs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Other Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Other Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Other Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 22: World Foot and Mouth Disease (FMD) Vaccine Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Table 23: USA Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 24: USA Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: USA 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 27: USA Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: USA 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
CANADA
  • Table 29: Canada Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 30: Canada Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 31: Canada 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 33: Canada Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 34: Canada 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
JAPAN
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • Table 35: Japan Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 36: Japan Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 37: Japan 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 39: Japan Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 40: Japan 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
CHINA
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • Table 41: China Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 42: China Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 43: China 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 45: China Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 46: China 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
EUROPE
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Table 47: Europe Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 48: Europe Historic Review for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 49: Europe 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 51: Europe Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 52: Europe 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 53: Europe Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 54: Europe Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 55: Europe 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
FRANCE
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 57: France Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 58: France 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 59: France Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 60: France Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 61: France 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
GERMANY
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 63: Germany Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 64: Germany 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 65: Germany Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 66: Germany Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 67: Germany 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 69: Italy Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 70: Italy 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 71: Italy Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 72: Italy Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 73: Italy 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
UNITED KINGDOM
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 75: UK Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 76: UK 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 77: UK Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 78: UK Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 79: UK 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
SPAIN
  • Table 80: Spain Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 81: Spain Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 82: Spain 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 83: Spain Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 84: Spain Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 85: Spain 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
RUSSIA
  • Table 86: Russia Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 87: Russia Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 88: Russia 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 89: Russia Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 90: Russia Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 91: Russia 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
REST OF EUROPE
  • Table 92: Rest of Europe Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 93: Rest of Europe Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 94: Rest of Europe 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 95: Rest of Europe Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 96: Rest of Europe Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 97: Rest of Europe 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
ASIA-PACIFIC
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • Table 98: Asia-Pacific Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 99: Asia-Pacific Historic Review for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 100: Asia-Pacific 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
  • Table 101: Asia-Pacific Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 102: Asia-Pacific Historic Review for Foot and Mouth Disease (FMD) Vaccine by Technique - Conventional Vaccines and Emergency Vaccines Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 103: Asia-Pacific 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Technique - Percentage Breakdown of Value Sales for Conventional Vaccines and Emergency Vaccines for the Years 2014, 2024 & 2030
  • Table 104: Asia-Pacific Recent Past, Current & Future Analysis for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
  • Table 105: Asia-Pacific Historic Review for Foot and Mouth Disease (FMD) Vaccine by Animal - Cattle, Sheep & Goat, Pigs and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 106: Asia-Pacific 16-Year Perspective for Foot and Mouth Disease (FMD) Vaccine by Animal - Percentage Breakdown of Value Sales for Cattle, Sheep & Goat, Pigs and Other Animals for the Years 2014, 2024 & 2030
AUSTRALIA
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Foot and Mouth Disease (FMD) Vaccine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Some of the 42 companies featured in this Global Foot and Mouth Disease (FMD) Vaccine market report include:
  • Agrovet Co
  • Beohringer Ingelheim
  • Biogénesis Bagó
  • Brilliant Bio Pharma Ltd.
  • Ceva Santé Animale
  • Empresa Colombiana de Productos Veterinarios S.A. VECOL S.A.
  • FMD Center
  • Godrej Agrovet Limited
  • Indian Immunologicals Limited
  • Limor de Colombia
  • Merck Animal Health
  • Merial S. A. S.
  • Vecol SA
  • Vetal Animal Health Products
  • Veterinary Serum and Vaccine Research Institute

Table Information